S.P. Domogatsky

Imtek (Russia)

Papers

1

Total Citations

20

H-Index

1

About

Dr. S.P. Domogatsky is a pioneering figure in the field of bioprinting and regenerative medicine, with a primary focus on developing clinically translatable technologies for tissue engineering. His most notable contribution is the development of the first commercial articulated collaborative in situ 3D bioprinter for skin wound healing, a groundbreaking device that enables direct printing of living tissues onto the human body during surgical procedures. This innovation addresses a critical bottleneck in clinical bioprinting by eliminating the need for bioreactors and post-printing maturation, allowing for immediate wound coverage and accelerated healing. With over 20 citations on this seminal 2023 work, Domogatsky’s research has rapidly gained recognition for its potential to revolutionize burn and chronic wound treatment. His work bridges the gap between laboratory-scale bioprinting and real-world clinical application, positioning him as a key innovator in translating advanced manufacturing techniques into practical surgical tools. By focusing on collaborative robotic systems and biocompatible hydrogels, Domogatsky continues to advance the frontier of personalized, on-demand tissue repair.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Commercial articulated collaborative in situ 3D bioprinter for skin wound healing
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Imtek (Russia)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago